NCT06234488 is a clinical trial in Breast Cancer, sponsored by Medical College of Wisconsin.

Who is sponsoring NCT06234488?

NCT06234488 is sponsored by Medical College of Wisconsin.

What condition does NCT06234488 study?

NCT06234488 studies Breast Cancer, Breast Neoplasms, Breast Adenocarcinoma, Breast Cancer Stage, Breast Cancer Stage IV, Breast Cancer Invasive, Breast Cancer in Situ.

Is NCT06234488 still recruiting?

NCT06234488 is currently active, enrolled. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT06234488

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Active, enrolled Last updated 12 January 2026

What this trial tests

trial in Breast Cancer in 125 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

8 December 2023

Primary endpoint
1 November 2024

30 August 2026

Quick facts

Lead sponsor	Medical College of Wisconsin
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	125
Start date	8 December 2023
Primary completion	1 November 2024
Estimated completion	30 August 2026
Sites	22 locations across United States

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Breast Neoplasms — all drugs for Breast Neoplasms →
Breast Adenocarcinoma — all drugs for Breast Adenocarcinoma →
Breast Cancer Stage — all drugs for Breast Cancer Stage →

Sponsor

Medical College of Wisconsin

Who can join

18 and older, any sex, with Breast Cancer or Breast Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Large Language Models for Automating Clinical Trial Criteria Conversion to Observational Medical Outcomes Partnership Common Data Model Queries: Validation and Evaluation Study.
Lee KH, Jang S, Kim GJ, Park S, et al · · 2025 · cited 2× · PMID 41100527 · DOI 10.2196/71252

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Medical College of Wisconsin trials

Trials by the same sponsor.

NCT07260552 — Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease · not yet recruiting
NCT06795360 — Weight Changes After Incretin-mimetics · NA · not yet recruiting
NCT07228208 — Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes · NA · not yet recruiting
NCT07298460 — Stimulation-based Therapy to Improve Balance in DCM · Phase 1, PHASE2 · not yet recruiting
NCT07434544 — Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06234488 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical College of Wisconsin
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06234488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing